SeaCrest Wealth Management LLC Trims Holdings in CVS Health Co. (NYSE:CVS)

SeaCrest Wealth Management LLC reduced its stake in CVS Health Co. (NYSE:CVS) by 0.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 42,589 shares of the pharmacy operator’s stock after selling 162 shares during the period. SeaCrest Wealth Management LLC’s holdings in CVS Health were worth $3,468,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Ellsworth Advisors LLC lifted its stake in CVS Health by 4.0% during the 4th quarter. Ellsworth Advisors LLC now owns 18,945 shares of the pharmacy operator’s stock worth $1,496,000 after acquiring an additional 734 shares in the last quarter. Saxon Interests Inc. acquired a new stake in shares of CVS Health during the fourth quarter worth about $323,000. Uncommon Cents Investing LLC grew its holdings in shares of CVS Health by 6.2% in the fourth quarter. Uncommon Cents Investing LLC now owns 33,500 shares of the pharmacy operator’s stock valued at $2,645,000 after purchasing an additional 1,955 shares in the last quarter. Lincoln Capital Corp purchased a new stake in CVS Health during the 4th quarter worth approximately $208,000. Finally, Trueblood Wealth Management LLC acquired a new stake in CVS Health during the 4th quarter worth approximately $225,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total value of $2,267,947.35. Following the completion of the sale, the executive vice president now owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. 0.25% of the stock is owned by corporate insiders.

CVS Health Stock Performance

NYSE:CVS traded up $0.33 during trading hours on Friday, reaching $79.76. 8,981,310 shares of the company’s stock were exchanged, compared to its average volume of 9,174,262. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $100.37 billion, a price-to-earnings ratio of 12.35, a P/E/G ratio of 1.05 and a beta of 0.51. CVS Health Co. has a 1-year low of $64.41 and a 1-year high of $83.25. The company has a 50-day moving average of $75.66 and a 200 day moving average of $73.46.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping the consensus estimate of $2.01 by $0.11. The business had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The business’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.99 earnings per share. Research analysts anticipate that CVS Health Co. will post 8.33 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.34%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. SVB Leerink assumed coverage on CVS Health in a research report on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective on the stock. HSBC started coverage on CVS Health in a research report on Friday, December 22nd. They set a “buy” rating and a $94.00 price objective for the company. StockNews.com cut shares of CVS Health from a “buy” rating to a “hold” rating in a report on Thursday, February 15th. TD Cowen lowered their price target on shares of CVS Health from $102.00 to $99.00 and set an “outperform” rating for the company in a report on Monday, December 11th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $87.00 target price on shares of CVS Health in a research note on Thursday, February 8th. Four equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and an average price target of $90.21.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.